nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—CA1—Reversible hydration of carbon dioxide—CA9—breast cancer	0.00706	0.173	CbGpPWpGaD
Methocarbamol—Carvedilol—HIF1A—breast cancer	0.0067	0.253	CrCbGaD
Methocarbamol—CA1—Erythrocytes take up carbon dioxide and release oxygen—HBA1—breast cancer	0.00656	0.16	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—ETS2—breast cancer	0.00305	0.0745	CbGpPWpGaD
Methocarbamol—Carvedilol—VEGFA—breast cancer	0.0027	0.102	CrCbGaD
Methocarbamol—Felbamate—CYP3A4—breast cancer	0.00207	0.078	CrCbGaD
Methocarbamol—Ranolazine—CYP2D6—breast cancer	0.00197	0.0741	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—PIM1—breast cancer	0.00191	0.0468	CbGpPWpGaD
Methocarbamol—Oxprenolol—CYP2D6—breast cancer	0.00172	0.0648	CrCbGaD
Methocarbamol—Ranolazine—CYP3A4—breast cancer	0.00169	0.0636	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—CSF1R—breast cancer	0.00163	0.0398	CbGpPWpGaD
Methocarbamol—Alprenolol—CYP2D6—breast cancer	0.00157	0.0593	CrCbGaD
Methocarbamol—Carvedilol—PTGS1—breast cancer	0.00142	0.0537	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—CD34—breast cancer	0.00133	0.0324	CbGpPWpGaD
Methocarbamol—Carvedilol—CYP1A1—breast cancer	0.0013	0.0491	CrCbGaD
Methocarbamol—CA1—C-MYB transcription factor network—TAB2—breast cancer	0.00124	0.0304	CbGpPWpGaD
Methocarbamol—Vomiting—Vinblastine—breast cancer	0.00117	0.00126	CcSEcCtD
Methocarbamol—Urticaria—Thiotepa—breast cancer	0.00116	0.00125	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—WNT1—breast cancer	0.00116	0.0283	CbGpPWpGaD
Methocarbamol—Body temperature increased—Thiotepa—breast cancer	0.00116	0.00124	CcSEcCtD
Methocarbamol—Headache—Vinblastine—breast cancer	0.00116	0.00124	CcSEcCtD
Methocarbamol—Angioedema—Paclitaxel—breast cancer	0.00115	0.00124	CcSEcCtD
Methocarbamol—Hypotension—Gemcitabine—breast cancer	0.00115	0.00123	CcSEcCtD
Methocarbamol—Insomnia—Irinotecan—breast cancer	0.00114	0.00123	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—breast cancer	0.00114	0.00122	CcSEcCtD
Methocarbamol—Vomiting—Tamoxifen—breast cancer	0.00114	0.00122	CcSEcCtD
Methocarbamol—Vertigo—Paclitaxel—breast cancer	0.00114	0.00122	CcSEcCtD
Methocarbamol—Syncope—Paclitaxel—breast cancer	0.00113	0.00122	CcSEcCtD
Methocarbamol—Dizziness—Goserelin—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Hypotension—Fluorouracil—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Leukopenia—Paclitaxel—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Rash—Tamoxifen—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinorelbine—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Dermatitis—Tamoxifen—breast cancer	0.00113	0.00121	CcSEcCtD
Methocarbamol—Somnolence—Mitoxantrone—breast cancer	0.00112	0.00121	CcSEcCtD
Methocarbamol—Somnolence—Irinotecan—breast cancer	0.00112	0.00121	CcSEcCtD
Methocarbamol—Headache—Tamoxifen—breast cancer	0.00112	0.0012	CcSEcCtD
Methocarbamol—Vomiting—Melphalan—breast cancer	0.00112	0.0012	CcSEcCtD
Methocarbamol—Insomnia—Gemcitabine—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Dyspepsia—Irinotecan—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Dyspepsia—Mitoxantrone—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Loss of consciousness—Paclitaxel—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Rash—Melphalan—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Flushing—Capecitabine—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Dermatitis—Melphalan—breast cancer	0.00111	0.00119	CcSEcCtD
Methocarbamol—Nausea—Vinblastine—breast cancer	0.0011	0.00118	CcSEcCtD
Methocarbamol—Insomnia—Fluorouracil—breast cancer	0.0011	0.00117	CcSEcCtD
Methocarbamol—Somnolence—Gemcitabine—breast cancer	0.0011	0.00117	CcSEcCtD
Methocarbamol—Convulsion—Paclitaxel—breast cancer	0.00109	0.00117	CcSEcCtD
Methocarbamol—Vomiting—Goserelin—breast cancer	0.00109	0.00117	CcSEcCtD
Methocarbamol—Pruritus—Vinorelbine—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Pain—Irinotecan—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Pain—Mitoxantrone—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Rash—Goserelin—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Hypersensitivity—Thiotepa—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Dermatitis—Goserelin—breast cancer	0.00108	0.00116	CcSEcCtD
Methocarbamol—Somnolence—Fluorouracil—breast cancer	0.00108	0.00115	CcSEcCtD
Methocarbamol—Headache—Goserelin—breast cancer	0.00107	0.00115	CcSEcCtD
Methocarbamol—Dyspepsia—Fluorouracil—breast cancer	0.00107	0.00114	CcSEcCtD
Methocarbamol—Nausea—Tamoxifen—breast cancer	0.00106	0.00114	CcSEcCtD
Methocarbamol—Pain—Gemcitabine—breast cancer	0.00105	0.00113	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—breast cancer	0.00105	0.00112	CcSEcCtD
Methocarbamol—Nausea—Melphalan—breast cancer	0.00104	0.00112	CcSEcCtD
Methocarbamol—Feeling abnormal—Mitoxantrone—breast cancer	0.00104	0.00112	CcSEcCtD
Methocarbamol—Feeling abnormal—Irinotecan—breast cancer	0.00104	0.00112	CcSEcCtD
Methocarbamol—Confusional state—Paclitaxel—breast cancer	0.00104	0.00112	CcSEcCtD
Methocarbamol—Pruritus—Thiotepa—breast cancer	0.00104	0.00111	CcSEcCtD
Methocarbamol—Pain—Fluorouracil—breast cancer	0.00104	0.00111	CcSEcCtD
Methocarbamol—Anaphylactic shock—Paclitaxel—breast cancer	0.00103	0.00111	CcSEcCtD
Methocarbamol—Nausea—Goserelin—breast cancer	0.00102	0.00109	CcSEcCtD
Methocarbamol—Dysgeusia—Capecitabine—breast cancer	0.00102	0.00109	CcSEcCtD
Methocarbamol—Feeling abnormal—Gemcitabine—breast cancer	0.00102	0.00109	CcSEcCtD
Methocarbamol—Shock—Paclitaxel—breast cancer	0.00101	0.00109	CcSEcCtD
Methocarbamol—Dizziness—Vinorelbine—breast cancer	0.00101	0.00109	CcSEcCtD
Methocarbamol—Urticaria—Mitoxantrone—breast cancer	0.001	0.00108	CcSEcCtD
Methocarbamol—Body temperature increased—Irinotecan—breast cancer	0.001	0.00107	CcSEcCtD
Methocarbamol—Body temperature increased—Mitoxantrone—breast cancer	0.001	0.00107	CcSEcCtD
Methocarbamol—Feeling abnormal—Fluorouracil—breast cancer	0.000998	0.00107	CcSEcCtD
Methocarbamol—Propranolol—CYP1A1—breast cancer	0.000991	0.0374	CrCbGaD
Methocarbamol—Drowsiness—Methotrexate—breast cancer	0.000988	0.00106	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—GATA3—breast cancer	0.000985	0.0241	CbGpPWpGaD
Methocarbamol—Vision blurred—Capecitabine—breast cancer	0.000977	0.00105	CcSEcCtD
Methocarbamol—Vomiting—Vinorelbine—breast cancer	0.000975	0.00105	CcSEcCtD
Methocarbamol—Body temperature increased—Gemcitabine—breast cancer	0.000974	0.00104	CcSEcCtD
Methocarbamol—Carvedilol—CYP2D6—breast cancer	0.00097	0.0366	CrCbGaD
Methocarbamol—Dizziness—Thiotepa—breast cancer	0.000968	0.00104	CcSEcCtD
Methocarbamol—Rash—Vinorelbine—breast cancer	0.000967	0.00104	CcSEcCtD
Methocarbamol—Dermatitis—Vinorelbine—breast cancer	0.000966	0.00104	CcSEcCtD
Methocarbamol—Hypotension—Paclitaxel—breast cancer	0.000964	0.00103	CcSEcCtD
Methocarbamol—Urticaria—Fluorouracil—breast cancer	0.000962	0.00103	CcSEcCtD
Methocarbamol—Headache—Vinorelbine—breast cancer	0.000961	0.00103	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—breast cancer	0.000961	0.00103	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—breast cancer	0.00096	0.00103	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—breast cancer	0.000959	0.00103	CcSEcCtD
Methocarbamol—Body temperature increased—Fluorouracil—breast cancer	0.000957	0.00103	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—breast cancer	0.000941	0.00101	CcSEcCtD
Methocarbamol—Insomnia—Paclitaxel—breast cancer	0.000933	0.001	CcSEcCtD
Methocarbamol—Vertigo—Capecitabine—breast cancer	0.000932	0.000999	CcSEcCtD
Methocarbamol—Hypersensitivity—Irinotecan—breast cancer	0.000932	0.000999	CcSEcCtD
Methocarbamol—Hypersensitivity—Mitoxantrone—breast cancer	0.000932	0.000999	CcSEcCtD
Methocarbamol—Vomiting—Thiotepa—breast cancer	0.000931	0.000998	CcSEcCtD
Methocarbamol—Syncope—Capecitabine—breast cancer	0.00093	0.000997	CcSEcCtD
Methocarbamol—Leukopenia—Capecitabine—breast cancer	0.000928	0.000995	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—breast cancer	0.000928	0.000995	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—breast cancer	0.000925	0.000991	CcSEcCtD
Methocarbamol—Rash—Thiotepa—breast cancer	0.000923	0.00099	CcSEcCtD
Methocarbamol—Dermatitis—Thiotepa—breast cancer	0.000922	0.000989	CcSEcCtD
Methocarbamol—Headache—Thiotepa—breast cancer	0.000917	0.000984	CcSEcCtD
Methocarbamol—Somnolence—Paclitaxel—breast cancer	0.000917	0.000983	CcSEcCtD
Methocarbamol—Loss of consciousness—Capecitabine—breast cancer	0.000911	0.000977	CcSEcCtD
Methocarbamol—Nausea—Vinorelbine—breast cancer	0.000911	0.000977	CcSEcCtD
Methocarbamol—Dyspepsia—Paclitaxel—breast cancer	0.000908	0.000973	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—breast cancer	0.000901	0.000966	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—breast cancer	0.000899	0.000964	CcSEcCtD
Methocarbamol—Hypersensitivity—Fluorouracil—breast cancer	0.000892	0.000957	CcSEcCtD
Methocarbamol—Pain—Paclitaxel—breast cancer	0.000882	0.000946	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—breast cancer	0.000881	0.000945	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—breast cancer	0.000874	0.000937	CcSEcCtD
Methocarbamol—Pruritus—Gemcitabine—breast cancer	0.000872	0.000935	CcSEcCtD
Methocarbamol—Nausea—Thiotepa—breast cancer	0.00087	0.000933	CcSEcCtD
Methocarbamol—Shock—Docetaxel—breast cancer	0.00086	0.000922	CcSEcCtD
Methocarbamol—Pruritus—Fluorouracil—breast cancer	0.000857	0.000919	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—breast cancer	0.000855	0.000917	CcSEcCtD
Methocarbamol—Confusional state—Capecitabine—breast cancer	0.000853	0.000915	CcSEcCtD
Methocarbamol—Feeling abnormal—Paclitaxel—breast cancer	0.00085	0.000911	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—breast cancer	0.000845	0.000906	CcSEcCtD
Methocarbamol—Dizziness—Irinotecan—breast cancer	0.000836	0.000897	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—breast cancer	0.000834	0.000894	CcSEcCtD
Methocarbamol—Shock—Capecitabine—breast cancer	0.000833	0.000893	CcSEcCtD
Methocarbamol—Carvedilol—CYP3A4—breast cancer	0.000832	0.0314	CrCbGaD
Methocarbamol—Conjunctivitis—Doxorubicin—breast cancer	0.000831	0.000892	CcSEcCtD
Methocarbamol—Urticaria—Paclitaxel—breast cancer	0.000819	0.000879	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—breast cancer	0.000817	0.000876	CcSEcCtD
Methocarbamol—Body temperature increased—Paclitaxel—breast cancer	0.000815	0.000874	CcSEcCtD
Methocarbamol—Vomiting—Mitoxantrone—breast cancer	0.000804	0.000862	CcSEcCtD
Methocarbamol—Vomiting—Irinotecan—breast cancer	0.000804	0.000862	CcSEcCtD
Methocarbamol—Dizziness—Fluorouracil—breast cancer	0.000801	0.000859	CcSEcCtD
Methocarbamol—Rash—Mitoxantrone—breast cancer	0.000797	0.000855	CcSEcCtD
Methocarbamol—Rash—Irinotecan—breast cancer	0.000797	0.000855	CcSEcCtD
Methocarbamol—Dermatitis—Mitoxantrone—breast cancer	0.000797	0.000854	CcSEcCtD
Methocarbamol—Dermatitis—Irinotecan—breast cancer	0.000797	0.000854	CcSEcCtD
Methocarbamol—Headache—Mitoxantrone—breast cancer	0.000792	0.000849	CcSEcCtD
Methocarbamol—Headache—Irinotecan—breast cancer	0.000792	0.000849	CcSEcCtD
Methocarbamol—Hypotension—Capecitabine—breast cancer	0.000791	0.000848	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—breast cancer	0.000791	0.000848	CcSEcCtD
Methocarbamol—Vomiting—Gemcitabine—breast cancer	0.000783	0.00084	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—breast cancer	0.000782	0.000838	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—breast cancer	0.000777	0.000833	CcSEcCtD
Methocarbamol—Rash—Gemcitabine—breast cancer	0.000777	0.000833	CcSEcCtD
Methocarbamol—Dermatitis—Gemcitabine—breast cancer	0.000776	0.000832	CcSEcCtD
Methocarbamol—Headache—Gemcitabine—breast cancer	0.000772	0.000827	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—breast cancer	0.00077	0.000826	CcSEcCtD
Methocarbamol—Vomiting—Fluorouracil—breast cancer	0.00077	0.000826	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—breast cancer	0.00077	0.000825	CcSEcCtD
Methocarbamol—Insomnia—Capecitabine—breast cancer	0.000766	0.000821	CcSEcCtD
Methocarbamol—Rash—Fluorouracil—breast cancer	0.000764	0.000819	CcSEcCtD
Methocarbamol—Dermatitis—Fluorouracil—breast cancer	0.000763	0.000818	CcSEcCtD
Methocarbamol—Hypersensitivity—Paclitaxel—breast cancer	0.00076	0.000815	CcSEcCtD
Methocarbamol—Headache—Fluorouracil—breast cancer	0.000759	0.000814	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—breast cancer	0.000756	0.000811	CcSEcCtD
Methocarbamol—Nausea—Irinotecan—breast cancer	0.000751	0.000805	CcSEcCtD
Methocarbamol—Nausea—Mitoxantrone—breast cancer	0.000751	0.000805	CcSEcCtD
Methocarbamol—Pain—Docetaxel—breast cancer	0.000748	0.000802	CcSEcCtD
Methocarbamol—Dyspepsia—Capecitabine—breast cancer	0.000745	0.000799	CcSEcCtD
Methocarbamol—Propranolol—CYP2D6—breast cancer	0.000737	0.0278	CrCbGaD
Methocarbamol—Nausea—Gemcitabine—breast cancer	0.000732	0.000785	CcSEcCtD
Methocarbamol—Pruritus—Paclitaxel—breast cancer	0.00073	0.000782	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—breast cancer	0.000728	0.00078	CcSEcCtD
Methocarbamol—Pain—Capecitabine—breast cancer	0.000724	0.000776	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—breast cancer	0.00072	0.000772	CcSEcCtD
Methocarbamol—Nausea—Fluorouracil—breast cancer	0.000719	0.000771	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—breast cancer	0.000713	0.000764	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—breast cancer	0.000708	0.000759	CcSEcCtD
Methocarbamol—Feeling abnormal—Capecitabine—breast cancer	0.000697	0.000748	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—breast cancer	0.000694	0.000744	CcSEcCtD
Methocarbamol—Carvedilol—ABCB1—breast cancer	0.000692	0.0261	CrCbGaD
Methocarbamol—Body temperature increased—Docetaxel—breast cancer	0.000691	0.000741	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—breast cancer	0.000691	0.000741	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—HES1—breast cancer	0.000687	0.0168	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—GSTM1—breast cancer	0.000683	0.0167	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—NCOR1—breast cancer	0.000683	0.0167	CbGpPWpGaD
Methocarbamol—Dizziness—Paclitaxel—breast cancer	0.000682	0.000731	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—breast cancer	0.000681	0.00073	CcSEcCtD
Methocarbamol—Urticaria—Capecitabine—breast cancer	0.000672	0.000721	CcSEcCtD
Methocarbamol—Body temperature increased—Capecitabine—breast cancer	0.000669	0.000717	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—breast cancer	0.000669	0.000717	CcSEcCtD
Methocarbamol—Vomiting—Paclitaxel—breast cancer	0.000656	0.000703	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—breast cancer	0.000655	0.000702	CcSEcCtD
Methocarbamol—Rash—Paclitaxel—breast cancer	0.00065	0.000697	CcSEcCtD
Methocarbamol—Dermatitis—Paclitaxel—breast cancer	0.00065	0.000697	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—breast cancer	0.000649	0.000696	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—breast cancer	0.000648	0.000695	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—breast cancer	0.000647	0.000693	CcSEcCtD
Methocarbamol—Headache—Paclitaxel—breast cancer	0.000646	0.000693	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—breast cancer	0.000644	0.000691	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—breast cancer	0.000635	0.000681	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—breast cancer	0.000635	0.000681	CcSEcCtD
Methocarbamol—Propranolol—CYP3A4—breast cancer	0.000632	0.0239	CrCbGaD
Methocarbamol—Anaphylactic shock—Methotrexate—breast cancer	0.00063	0.000676	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—breast cancer	0.00063	0.000676	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—breast cancer	0.000626	0.000671	CcSEcCtD
Methocarbamol—Hypersensitivity—Capecitabine—breast cancer	0.000624	0.000669	CcSEcCtD
Methocarbamol—Pruritus—Docetaxel—breast cancer	0.000618	0.000663	CcSEcCtD
Methocarbamol—Nausea—Paclitaxel—breast cancer	0.000613	0.000657	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—breast cancer	0.000601	0.000644	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—breast cancer	0.000599	0.000643	CcSEcCtD
Methocarbamol—Pruritus—Capecitabine—breast cancer	0.000599	0.000642	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—breast cancer	0.000598	0.000642	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—breast cancer	0.000595	0.000638	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—breast cancer	0.00059	0.000632	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—breast cancer	0.000589	0.000631	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—breast cancer	0.000588	0.00063	CcSEcCtD
Methocarbamol—Shock—Epirubicin—breast cancer	0.00058	0.000622	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—breast cancer	0.000579	0.000621	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—breast cancer	0.000578	0.00062	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—breast cancer	0.00057	0.000611	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—breast cancer	0.00056	0.000601	CcSEcCtD
Methocarbamol—Dizziness—Capecitabine—breast cancer	0.00056	0.0006	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—breast cancer	0.000556	0.000596	CcSEcCtD
Methocarbamol—Dyspepsia—Methotrexate—breast cancer	0.000555	0.000595	CcSEcCtD
Methocarbamol—Rash—Docetaxel—breast cancer	0.000551	0.000591	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—breast cancer	0.000551	0.000591	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—breast cancer	0.000551	0.00059	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—breast cancer	0.00055	0.00059	CcSEcCtD
Methocarbamol—Headache—Docetaxel—breast cancer	0.000548	0.000587	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—breast cancer	0.000546	0.000585	CcSEcCtD
Methocarbamol—Pain—Methotrexate—breast cancer	0.000539	0.000578	CcSEcCtD
Methocarbamol—Vomiting—Capecitabine—breast cancer	0.000538	0.000577	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—breast cancer	0.000537	0.000576	CcSEcCtD
Methocarbamol—Rash—Capecitabine—breast cancer	0.000534	0.000572	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—breast cancer	0.000533	0.000572	CcSEcCtD
Methocarbamol—Dermatitis—Capecitabine—breast cancer	0.000533	0.000572	CcSEcCtD
Methocarbamol—Headache—Capecitabine—breast cancer	0.00053	0.000569	CcSEcCtD
Methocarbamol—Propranolol—ABCB1—breast cancer	0.000527	0.0199	CrCbGaD
Methocarbamol—Somnolence—Epirubicin—breast cancer	0.000524	0.000562	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—breast cancer	0.000519	0.000557	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—breast cancer	0.000519	0.000557	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—breast cancer	0.000519	0.000557	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—breast cancer	0.00051	0.000547	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—KIT—breast cancer	0.000507	0.0124	CbGpPWpGaD
Methocarbamol—Pain—Epirubicin—breast cancer	0.000504	0.000541	CcSEcCtD
Methocarbamol—Nausea—Capecitabine—breast cancer	0.000503	0.000539	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—breast cancer	0.000501	0.000537	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—breast cancer	0.000498	0.000534	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—breast cancer	0.000493	0.000529	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—breast cancer	0.000486	0.000521	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—breast cancer	0.000485	0.00052	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—breast cancer	0.00048	0.000515	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—breast cancer	0.000468	0.000502	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—breast cancer	0.000467	0.0005	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—breast cancer	0.000466	0.0005	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—breast cancer	0.000464	0.000498	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—breast cancer	0.00045	0.000482	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—breast cancer	0.000446	0.000478	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—breast cancer	0.000434	0.000466	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—breast cancer	0.000433	0.000465	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—breast cancer	0.000431	0.000462	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—breast cancer	0.000417	0.000447	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—breast cancer	0.000417	0.000447	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—BCL2—breast cancer	0.000405	0.00992	CbGpPWpGaD
Methocarbamol—Hypersensitivity—Doxorubicin—breast cancer	0.000402	0.000431	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—breast cancer	0.000401	0.00043	CcSEcCtD
Methocarbamol—Rash—Methotrexate—breast cancer	0.000397	0.000426	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—breast cancer	0.000397	0.000426	CcSEcCtD
Methocarbamol—Headache—Methotrexate—breast cancer	0.000395	0.000423	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—breast cancer	0.00039	0.000418	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—CD4—breast cancer	0.000388	0.00949	CbGpPWpGaD
Methocarbamol—Pruritus—Doxorubicin—breast cancer	0.000386	0.000414	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—PTGS2—breast cancer	0.000385	0.00942	CbGpPWpGaD
Methocarbamol—Vomiting—Epirubicin—breast cancer	0.000375	0.000402	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—breast cancer	0.000374	0.000401	CcSEcCtD
Methocarbamol—Rash—Epirubicin—breast cancer	0.000372	0.000399	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—breast cancer	0.000371	0.000398	CcSEcCtD
Methocarbamol—Headache—Epirubicin—breast cancer	0.000369	0.000396	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—CDKN1B—breast cancer	0.000365	0.00892	CbGpPWpGaD
Methocarbamol—Dizziness—Doxorubicin—breast cancer	0.000361	0.000387	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—breast cancer	0.00035	0.000376	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—CCND1—breast cancer	0.000348	0.00851	CbGpPWpGaD
Methocarbamol—Vomiting—Doxorubicin—breast cancer	0.000347	0.000372	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—breast cancer	0.000344	0.000369	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—breast cancer	0.000344	0.000369	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—breast cancer	0.000342	0.000366	CcSEcCtD
Methocarbamol—CA1—C-MYB transcription factor network—CDKN1A—breast cancer	0.000337	0.00823	CbGpPWpGaD
Methocarbamol—Nausea—Doxorubicin—breast cancer	0.000324	0.000347	CcSEcCtD
Methocarbamol—CA1—Metabolism—SYNJ2—breast cancer	0.000294	0.00718	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—MYC—breast cancer	0.000279	0.00683	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NDUFS3—breast cancer	0.000273	0.00668	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—KRAS—breast cancer	0.000258	0.00631	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CHST9—breast cancer	0.000257	0.00628	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—COX11—breast cancer	0.000243	0.00595	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CDA—breast cancer	0.000223	0.00544	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SHMT1—breast cancer	0.000223	0.00544	CbGpPWpGaD
Methocarbamol—CA1—C-MYB transcription factor network—HRAS—breast cancer	0.000219	0.00536	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A5—breast cancer	0.000214	0.00524	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLCO1B1—breast cancer	0.000214	0.00524	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—APRT—breast cancer	0.000207	0.00506	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ANGPTL4—breast cancer	0.000194	0.00476	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ESRRA—breast cancer	0.000194	0.00476	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HADHB—breast cancer	0.000184	0.00451	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPI—breast cancer	0.000184	0.00451	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALDH7A1—breast cancer	0.000176	0.0043	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALDH1A1—breast cancer	0.000176	0.0043	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ADSL—breast cancer	0.000169	0.00413	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PHGDH—breast cancer	0.000169	0.00413	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—UMPS—breast cancer	0.000169	0.00413	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NME1—breast cancer	0.000169	0.00413	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—FHL2—breast cancer	0.000169	0.00413	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—BRIP1—breast cancer	0.000165	0.00405	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HPSE—breast cancer	0.000165	0.00405	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—LDHB—breast cancer	0.000165	0.00405	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ABCC1—breast cancer	0.000157	0.00383	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTA3—breast cancer	0.000157	0.00383	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HMMR—breast cancer	0.000157	0.00383	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PPARGC1B—breast cancer	0.000152	0.00371	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTA4—breast cancer	0.000143	0.00351	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CA9—breast cancer	0.000143	0.00351	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTA2—breast cancer	0.00014	0.00342	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX2—breast cancer	0.00014	0.00342	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX4—breast cancer	0.000138	0.00338	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SULT1A1—breast cancer	0.000138	0.00338	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—IDH1—breast cancer	0.000135	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTA1—breast cancer	0.000135	0.0033	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NAT2—breast cancer	0.000133	0.00326	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—DPYD—breast cancer	0.000117	0.00286	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MED12—breast cancer	0.000117	0.00286	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALDOA—breast cancer	0.000115	0.00281	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NCOA3—breast cancer	0.000112	0.00273	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A2—breast cancer	0.000111	0.00271	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CPT1A—breast cancer	0.000109	0.00266	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MTR—breast cancer	0.000109	0.00266	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ABCG2—breast cancer	0.000109	0.00266	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HPGDS—breast cancer	0.000107	0.00261	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HBA1—breast cancer	0.000106	0.00259	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTT1—breast cancer	0.000103	0.00253	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ACHE—breast cancer	0.000103	0.00253	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP17A1—breast cancer	9.78e-05	0.00239	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTGS1—breast cancer	9.69e-05	0.00237	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ENO1—breast cancer	9.69e-05	0.00237	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP2D6—breast cancer	9.5e-05	0.00232	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NCOA2—breast cancer	9.32e-05	0.00228	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—FASN—breast cancer	9.04e-05	0.00221	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—BCHE—breast cancer	9e-05	0.0022	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC5A5—breast cancer	8.89e-05	0.00218	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—SLC2A1—breast cancer	8.59e-05	0.0021	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NQO1—breast cancer	8.59e-05	0.0021	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP3A4—breast cancer	8.38e-05	0.00205	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP1B1—breast cancer	8.24e-05	0.00201	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HSP90AA1—breast cancer	8.08e-05	0.00198	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NCOA1—breast cancer	7.86e-05	0.00192	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—STK11—breast cancer	7.74e-05	0.00189	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP19A1—breast cancer	7.74e-05	0.00189	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—COMT—breast cancer	7.2e-05	0.00176	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTP1—breast cancer	7.16e-05	0.00175	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—HMOX1—breast cancer	7.07e-05	0.00173	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ITPR1—breast cancer	7.05e-05	0.00172	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ABCB1—breast cancer	6.78e-05	0.00166	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—TYMS—breast cancer	6.66e-05	0.00163	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NCOR1—breast cancer	6.58e-05	0.00161	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PLA2G4A—breast cancer	6.58e-05	0.00161	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GSTM1—breast cancer	6.58e-05	0.00161	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—GPX1—breast cancer	6.3e-05	0.00154	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CYP1A1—breast cancer	6.24e-05	0.00153	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ERCC2—breast cancer	6.19e-05	0.00151	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—MTHFR—breast cancer	5.82e-05	0.00142	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—CAV1—breast cancer	5.37e-05	0.00131	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PIK3CG—breast cancer	4.89e-05	0.0012	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PIK3CD—breast cancer	4.3e-05	0.00105	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—ALB—breast cancer	4.24e-05	0.00104	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—NOS3—breast cancer	4.06e-05	0.000993	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PIK3CB—breast cancer	3.75e-05	0.000916	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTGS2—breast cancer	3.71e-05	0.000908	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PTEN—breast cancer	3.24e-05	0.000792	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—PIK3CA—breast cancer	2.28e-05	0.000559	CbGpPWpGaD
Methocarbamol—CA1—Metabolism—AKT1—breast cancer	1.87e-05	0.000456	CbGpPWpGaD
